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Trypanosomiasis and leishmaniasis are important parasitic diseases affecting millions of people in Africa,
Asia, and South America. In a previous study, we identified several flavonoid glycosides as antiprotozoal
principles from a Turkish plant. Here we surveyed a large set of flavonoid aglycones and glycosides, as well as
a panel of other related compounds of phenolic and phenylpropanoid nature, for their in vitro activities against
Trypanosoma brucei rhodesiense, Trypanosoma cruzi, and Leishmania donovani. The cytotoxicities of more than
100 compounds for mammalian L6 cells were also assessed and compared to their antiparasitic activities.
Several compounds were investigated in vivo for their antileishmanial and antitrypanosomal efficacies in
mouse models. Overall, the best in vitro trypanocidal activity for T. brucei rhodesiense was exerted by 7,8-
dihydroxyflavone (50% inhibitory concentration [IC50], 68 ng/ml), followed by 3-hydroxyflavone, rhamnetin,
and 7,8,3,4-tetrahydroxyflavone (IC50s, 0.5 g/ml) and catechol (IC50, 0.8 g/ml). The activity against T. cruzi
was moderate, and only chrysin dimethylether and 3-hydroxydaidzein had IC50s less than 5.0 g/ml. The
majority of the metabolites tested possessed remarkable leishmanicidal potential. Fisetin, 3-hydroxyflavone,
luteolin, and quercetin were the most potent, giving IC50s of 0.6, 0.7, 0.8, and 1.0 g/ml, respectively.
7,8-Dihydroxyflavone and quercetin appeared to ameliorate parasitic infections in mouse models. Generally,
the test compounds lacked cytotoxicity in vitro and in vivo. By screening a large number of flavonoids and
analogues, we were able to establish some general trends with respect to the structure-activity relationship, but
it was not possible to draw clear and detailed quantitative structure-activity relationships for any of the
bioactivities by two different approaches. However, our results can help in directing the rational design of
7,8-dihydroxyflavone and quercetin derivatives as potent and effective antiprotozoal agents.
Trypanosomiasis and leishmaniasis have reemerged over the
last few decades as important threats to human health and
economical development. Human African trypanosomiasis,
also known as sleeping sickness, is caused by Trypanosoma
brucei rhodesiense and Trypanosoma brucei gambiense and is a
major cause of mortality and morbidity in sub-Saharan Africa.
Currently, human African trypanosomiasis occurs in 36 Afri-
can countries and about 60 million people are at risk (16).
Trypanosoma cruzi is the causative agent of American trypano-
somiasis (also known as Chagas’ disease), which is a major
endemic disease in Latin America. The number of people
infected is estimated to be from 16 million to 18 million, with
a further 100 million considered at risk (7). Leishmaniasis is a
vector-borne disease, affecting 72 developing countries and 13
of the least developed countries. Visceral leishmaniasis due to
Leishmania donovani is the most severe form of Leishmania
infections. The annual incidence of visceral leishmaniasis is
estimated to be 500,000 cases. The overall prevalence of vis-
ceral leishmaniasis is 12 million people, and the population at
risk is 350 million (6). If they are left untreated, both Trypano-
soma and Leishmania infections can be fatal. The current
treatment regimens, based on chemotherapy, for these para-
sitic diseases are limited and are not ideal, as they are often
associated with severe side effects. The emergence of drug-
resistant parasites presents an additional and major problem.
All these facts underline the urgent need for the development
of new, cheap, safe, and easy-to-administer molecules for the
treatment of these infectious diseases.
Flavonoids are a large group of polyphenolic compounds
possessing a basic flavan nucleus with two aromatic rings (the
A and the B rings) interconnected by a three-carbon-atom
heterocyclic ring (the C ring). The most widespread flavonoids
contain a double bond between C-2 and C-3 (2,3) and a keto
function at C-4 of ring C, which is attached to ring B at C-2
(flavone) or at C-3 (isoflavone). As a result of a number of
further modifications on all three rings, particularly on ring C,
flavonoids represent one of the largest and the most diverse class
of plant secondary metabolites. These compounds are naturally
present in vegetables, fruits, and beverages and thus are impor-
tant components of the daily Western diet. Flavonoids have been
known for a long time to exert diverse biological effects (biofla-
* Corresponding author. Mailing address: Institute of Organic Chem-
istry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zu¨rich,
Switzerland. Phone: 41-1-635 42 13. Fax: 41-1-635 68 12. E-mail: deniz
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vonoids) and in particular to act as antioxidants and preventive
agents against cancer (10). They are also common constituents of
medicinal plants, and the therapeutic effects of many traditional
medicines have been ascribed to these phytochemicals. We and
others have recently identified several types of flavonoids as an-
tiprotozoal principles of plant extracts (3, 9, 12, 17, 32, 33), but
a comprehensive study of their structure-activity relationships
(SARs) has not been conducted so far. Therefore, it was our
interest to assess the in vitro trypanocidal and leishmanicidal
activities of a large flavonoid library, as well as a panel of other
related phenolic and phenylpropanoid compounds; draw SARs, if
possible; and determine their antiparasitic selectivities. The
present study underlines the in vitro ability of flavonoids and
structurally related phenolic compounds to inhibit trypanosomal
and leishmanial infections without significant toxicity to mamma-
lian cells. However, their low bioavailability indicates the need for
detailed mechanistic studies together with the development of
parasite-specific formulations and delivery systems.
MATERIALS AND METHODS
Materials. Aldrich Chemical Co. (Milwaukee, WI) supplied flavone, 6-hydroxy-
flavone, 3,6-dihydroxyflavone, 3,7-dihydroxyflavone, and trans-ferulic acid samples,
while Sigma (St. Louis, MO) supplied 5- and 7-hydroxyflavones, all catechin-type
compounds, scopoletin, 4-hydroxycoumarin, umbelliferone, 4-methylumbelliferone,
gallic acid, 2,3- and 3,4-dihydroxybenzoic acids, and o- and p-coumaric acids. 3-Hy-
droxyflavone was purchased from ABCR GmbH & Co. (Karlsruhe, Germany).
5,7-Dihydroxyflavone (chrysin), apigenin, luteolin, galangin, kaempferol, fisetin,
quercetin dihydrate, myricetin, morin dihydrate, catechol, pyrogallol, and all other
cinnamic acid derivatives were purchased from Fluka (Buchs, Switzerland). Roth
(Karlsruhe, Germany) supplied vitexin, rutin, quercetin-3,7,3,4-tetramethylether,
7,8-dimethoxyflavone, naringenin, 5,7-dimethoxy-8-methylflavanone, 5,4-dihydroxy-
6,7-dimethoxyflavanone, hesperidine, and neohesperidine. Ladanein, 5,4-dihy-
droxy-6,7-dimethoxyflavanone, cirsimaritin, and genkwanin were previously isolated
from plants of the family Lamiaceae (2, 13, 21, 34), whereas luteolin-7-O-rutinoside
was previously obtained from Gonocytisus angulatus (35). Their purities (95%)
were determined by thin-layer chromatography and 1H nuclear magnetic resonance
imaging. All remaining compounds were purchased from Extrasynthese (Genay,
France). The commercial chemicals were of the highest grade available (purities, 95
to 99%).
In vitro assay for Leishmania donovani. Amastigotes of Leishmania donovani
strain MHOM/ET/67/L82 were grown in axenic culture at 37°C in SM medium
(5), at pH 5.4, supplemented with 10% heat-inactivated fetal bovine serum under
an atmosphere of 5% CO2 in air. One hundred microliters of culture medium
with 1  105 amastigotes from axenic culture with or without a serial drug
dilution was seeded in 96-well microtiter plates. Seven threefold dilutions cov-
ering a range from 30 to 0.041 g/ml were used. After 72 h of incubation, 10 l
of Alamar Blue was added to each well. The plates were incubated for another
2 h and read with a Spectramax Gemini XS microplate fluorometer (Molecular
Devices Cooperation, Sunnyvale, CA) by using an excitation wavelength of 536
nm and an emission wavelength of 588 nm. The data were analyzed by using the
software Softmax Pro (Molecular Devices Cooperation). The decrease of fluo-
rescence (which indicated inhibition) was expressed as the percentage of the
fluorescence of the control cultures and was plotted against the drug concentra-
tions. The 50% inhibitory concentrations (IC50s) were calculated from the sig-
moidal inhibition curves.
In vitro assays for Trypanosoma brucei rhodesiense and L6 cell cytotoxicity.
Minimum essential medium (50 l) supplemented, as described previously (1),
with 2-mercaptoethanol and 15% heat-inactivated horse serum was added to
each well of a 96-well microtiter plate. Serial drug dilutions covering a range
from 90 to 0.123 g/ml were prepared. Then, 104 bloodstream forms of Trypano-
soma brucei rhodesiense STIB 900 in 50 l were added to each well, and the plate
was incubated at 37°C under a 5% CO2 atmosphere for 72 h. After addition of
10 l of Alamar Blue to each well, the plates were incubated for another 2 to 4 h
and read in a Spectramax Gemini XS microplate fluorometer by using an exci-
tation wavelength of 536 nm and an emission wavelength of 588 nm (31).
Fluorescence development was expressed as the percentage of that for the
control, and IC50s were determined. Cytotoxicity was assessed by using the same
assay with rat skeletal myoblasts (L6 cells).
In vitro assay for Trypanosoma cruzi. Rat skeletal myoblasts (L6 cells) were
seeded in 96-well microtiter plates at 2,000 cells/well in 100 l RPMI 1640
medium with 10% fetal bovine serum and 2 mM L-glutamine. After 24 h, the
medium was removed and replaced by 100 l per well containing 5,000 trypo-
mastigote forms of T. cruzi Tulahuen strain C2C4 containing the -galactosidase
(LacZ) gene. Forty-eight hours later, the medium was removed from the wells
and replaced by 100 l fresh medium with or without a serial drug dilution. After
96 h of incubation, the substrate chlorophenol red--D-galactopyranoside
(CPRG)-Nonidet (50 l) was added to all wells. A color reaction developed
within 2 to 6 h and was read photometrically at 540 nm. Data were transferred
into a graphic program (e.g., Microsoft Excel), sigmoidal inhibition curves
were determined, and IC50s were calculated.
In vivo activity assessments. The assay procedures, the administration route,
and the doses of the test compounds have been selected on the basis of the
standard operating procedure that has been devised within the TDR-WHO
mandate. All compounds were injected by the intraperitoneal (i.p.) route,
based on our experience that a new test compound has the best chance to
show activity when it is administered abdominally. The selected standard
dosage should be high enough but should still ensure the absence of toxicity.
The agreed-upon standard operating procedure also allows the screeners to
compare data (with those for positive control drugs) and to perform duplicate
experiments.
In vivo assay for Leishmania donovani. Female BALB/c mice (weight, 20 g;
Charles Rivers, United Kingdom) were infected with 2  107 amastigotes in a
0.2-ml bolus via a lateral tail vein. The mice were then randomly sorted into
groups of five mice each. L. donovani HU3 amastigotes were harvested from a
passage animal immediately prior to infection (4). At 7 days postinfection, the
mice were dosed intraperitoneally at 30 mg/kg of body weight/day for 5 consec-
utive days. At 14 days postinfection, all mice were killed; the livers were weighed;
and impression smears were made on glass slides, which were then fixed and stained.
Antileishmanial activity was evaluated by counting the number of amastigotes per
500 host cell nuclei and multiplying that value by the weight of the liver (mg). That
value was then compared to the values for the untreated controls. Treatment with
the standard drugs pentostam (sodium stibogluconate, 15 mg/kg subcutaneously
[s.c.] for 5 days) and oral miltefosine (30 mg/kg for 5 days) was also included as a
positive control.
In vivo assay for Trypanosoma brucei brucei. Groups of four female NMRI
mice weighing 20 to 25 g were infected i.p. on day 0 (d0) with 105 bloodstream
forms of Trypanosoma brucei brucei STIB 795, which is a derivative of strain 427.
Mice were treated on 4 consecutive days (d3 to d6 postinfection) with 50 mg/kg
by the i.p. route. One group served as untreated controls, and two other groups
were treated with the standard drugs pentamidine (5 mg/kg for 4 days) and
melarsoprol (2 mg/kg for 4 days), respectively. The levels of parasitemia of the
mice were checked by examination of tail blood on day 7 and thereafter twice a
week. The day of death of the mice was recorded.
Molecular modeling and QSAR analyses. Molecular models were generated
with the program package MOE (27). For documentation of the quantitative
structure-activity relationship (QSAR) descriptors calculated by MOE, see http:
//www.chemcomp.com/Journal_of_CCG/Features/descr.htm. The energies of the
initial geometries were minimized by using the MMFF94x force field. For each
compound, a stochastic conformational search was carried out, and the energies
of the lowest-energy conformers found were minimized by using the semiempirical
AM1 Hamiltonian. Descriptors for the partial least-squares (PLS) analysis were
generated on the basis of the lowest-energy conformer of each compound by using
the MOE module MOE Descriptor, and PLS analysis was carried out by using MOE
QuaSAR. For modeling by the use of the Raptor program Biographics Laboratory
3R, Basel, Switzerland [http://www.biograf.ch/]), the molecules were aligned as de-
scribed in the Results and imported into Raptor in mol2 format. For each com-
pound, the two lowest-energy B-ring rotamers were included. Test set compounds
were selected randomly. Binding site modeling was carried out by using Raptor
version 2.0 (20) and applying default settings.
RESULTS
In vitro antileishmanial activity. All 105 compounds were inves-
tigated for their activities against axenic L. donovani amastigotes,
the clinically relevant form of the parasite; and the results are
illustrated in Tables 1 to 7. With few exceptions, all flavone and
flavon-3-ol type aglycones showed significant antileishmanial ac-
tivity, with fisetin (IC50, 0.6 g/ml), 3-hydroxyflavone (IC50, 0.7
g/ml), and luteolin (IC50, 0.8 g/ml) being the most potent.
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Their IC50s were almost comparable to that of miltefosine (IC50,
0.34 g/ml), the antileishmanial drug used in the clinic. Also,
quercetin was a potent leishmanicidal agent, with an IC50 of 1.0
g/ml. Among the remaining compounds, 18 had IC50s that
ranged from 1.1 to 3.0 g/ml. These 18 compounds included 6
flavones and 4 flavone glycosides, 5 flavon-3-ols, 1 flavanone, 1
isoflavone, and 1 coumarin derivative. Thirty compounds (11 fla-
vones, 6 flavonols, 1 biflavone, 1 flavanone, 1 isoflavone, 1 flavan-
3-ol, 2 simple phenolic compounds, and 7 cinnamates) displayed
IC50s that ranged from 3.1 to 10 g/ml.
TABLE 1. In vitro antiprotozoal and cytotoxic activities of flavones (aglycones and glycosides) and biflavonoidsa
Class No. forQSAR Compound
Position(s)
of OH
Position(s) of
OMe (or Me)
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
Standards 0.34b 0.0026c 0.328d 0.008e
Flavone 1 Flavone 5.0 (8.5)f 6.4 (6.6) 25.8 (1.6) 42.3
Aglycone 2 5-Hydroxyflavone (primuletin) 5 5.5 10.6 30 90
3 5-Methoxyflavone 5 13.4 (2.8) 15.0 (2.5) 6.1 (6.2) 37.7
4 6-Hydroxyflavone 6 5.4 (7.5) 3.3 (12.2) 23.1 (1.7) 40.4
5 6-Methoxyflavone 6 30 29.4 19.6 90
6 7-Hydroxyflavone 7 4.1 (10.8) 6.6 (6.7) 30 44.1
7 7-Methoxyflavone 7 29.2 (1.3) 14.3 (2.7) 7.0 (5.5) 38.4
8 Chrysin 5,7 2.2 (14.8) 5.3 (6.1) 20.6 (1.6) 32.5
9 Tectochrysin 5 7 30 86.2 12.8 90
10 Chrysin dimethylether 5,7 30 7.9 (2.7) 3.9 (5.5) 21.5
11 6,7-Dihydroxyflavone 6,7 6.2 (2.6) 1.9 (8.5) 18.0 (0.9) 16.1
12 7,8-Dihydroxyflavone 7,8 1.7 (4.6) 0.068 (116.2) 6.6 (1.2) 7.9
13 7,8-Dimethoxyflavone 7,8 9.6 (5.0) 6.1 (7.9) 30 48.4
14 7,4-Dihydroxyflavone 7,4 11.1 (7.6) 6.9 (12.3) 30 84.7
15 Apigenin 5,7,4 1.9 (9.5) 5.1 (3.5) 21.8 (0.8) 18.1
16 Genkwanin 5,4 7 9.4 8.0 30 90
17 Ladanein 5,6 7,4 2.1 (14.5) 2.5 (12.2) 25.2 (1.2) 30.6
18 Cirsimaritin 5,4 6,7 3.9 (4.3) 3.3 (5.1) 19.7 (0.9) 16.7
19 Scutellarein 5,6,7,4 2.6 (18.5) 4.6 (10.5) 30 48.2
20 3,4-Dihydroxyflavone 3,4 2.0 (8.2) 1.1 (14.9) 10.1 (1.6) 16.4
21 7,3,4-Trihydroxyflavone 7,3,4 5.5 (3.8) 4.5 (4.7) 22.6 (0.9) 21.0
22 Luteolin 5,7,3,4 0.8 (11.8) 3.7 (2.5) 21.4 (0.4) 9.4
23 Diosmetin 5,7,3 4 7.1 (10.9) 6.1 (12.7) 30 77.6
24 Luteolin tetramethylether 5,7,3,4 30 4.4 17.3 90
25 7,8,3,4-Tetrahydroxyflavone 7,8,3,4 8.8 (2.5) 0.5 (43.2) 24.5 (0.9) 21.6
26 7,8,3,4-Tetramethoxyflavone 7,8,3,4 30 67.2 30 90
Glycoside Apigenin-7-O-glucoside 5,4; 7-O-Glu 2.1 (34.6) 22.7 (3.2) 30 72.6
Luteolin-5-O-glucoside 7,3,4; 5-O-Glu 3.0 39.0 30 90
Luteolin-7-O-glucosideg 5,3,4; 7-O-Glu 1.1 60.6 90 90
Luteolin-7-O-rutinoside 5,3,4; 7-O-Rut 2.6 (24.1) 28.7 (2.2) 30 62.7
Vitexin 5,7,4 8-C-Glu 30 55.7 30 90
Biflavone Amentoflavone The structure is
shown above
6.0 (12.3) 22.7 (3.2) 30 73.6
a The IC50s are mean values from at least two replicates (the variation is a maximum of 20%). Abbreviations: Glu, glucose; Rut, rutinose (6-O-rhamnopyranosyl-
glucose); OMe, methoxyl; Me, methyl.
b Reference compound, miltefosine.
c Reference compound, melarsoprol.
d Reference compound, benznidazole.
e Reference compound, phodophyllotoxin.
f Selectivity indices are given in parentheses.
g These data are from our previous work (17).
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Starting with the flavones (Table 1), the insertion of a single
OH group at the benzo--chromone portion of the flavone
structure did not have a notable influence, but insertion of two
OH functions significantly enhanced the leishmanicidal potential.
Particularly important positions were C-5, C-7, and C-8. Hydroxy-
lation on ring B had some impact on the activity, but a clear SAR
could not be observed. For instance, luteolin, which contains a
catechol(3,4-dihydroxyphenyl)moietyanda5,7-dihydroxybenzo-
chromone structure, was twice as efficacious (IC50, 0.8 g/ml) as
apigenin, which contains a p-hydroxyphenyl side chain (IC50, 1.9
g/ml). In turn, apigenin was only slightly more active than chry-
sin (IC50, 2.2 g/ml), which has an unsubstituted B ring. On the
other hand, 7-hydroxyflavone was more active (IC50, 4.1 g/ml)
than 7,4-dihydroxyflavone (IC50, 11.1 g/ml) and was equally as
active as 7,3,4-trihydroxyflavone (IC50, 5.5 g/ml). A good an-
tileishmanial potential was exerted by 3,4-dihydroxyflavone itself
(IC50, 2.0 g/ml). The best combination was represented by lute-
olin, which has four OH groups at C-5, C-7, C-3, and C-4.
7,8-Dihydroxyflavone had the second best activity among the fla-
vone aglycones (IC50, 1.7 g/ml), but the addition of a catechol
structure into the B ring (7,8,3,4-tetrahydroxyflavone) dimin-
ished the activity almost fivefold (IC50, 8.8 g/ml). Replacement
of the OH groups, either on the benzochromone skeleton or on
the side chain, by methoxyl groups decreased the activity at least
twofold. For example, apigenin had an IC50 of 1.9 g/ml, whereas
the IC50 of genkwanin (7-methoxyapigenin) was 9.4 g/ml. More-
over, it seemed that the higher the numbers of methoxyl functions
that there were, the lower the leishmanicidal potential was, for
example, as in the case of luteolin (IC50, 0.8 g/ml), diosmetin
(IC50, 7.1 g/ml), and luteolin-tetramethylether (IC50, 30 g/
ml). Attachment of one or more sugar units at the C-5 or the C-7
position of the flavone skeleton, at least for the compounds api-
genin and luteolin studied here, caused a slight to appreciable
reduction in antileishmanial potency. The apigenin dimer ament-
oflavone, the only biflavonoid investigated here, also had some
antileishmanial effect (IC50, 6.0 g/ml) (Table 1).
The compounds with the highest levels of antileishmanial
activity were found in the flavon-3-ol (flavonol) series (Table
2). The simplest flavonol, 3-hydroxyflavone (IC50, 0.7 g/ml),
was seven times more potent than flavone (IC50, 5.0 g/ml).
The compounds with further hydroxylations at position 5, 6, or
7 were also active; but they were not as potent as 3-hydroxy-
flavone. The number and the pattern of hydroxylation on ring B
had an influence on the activity, but again, clear SARs could not
be determined. The best combination was presented by fisetin
(IC50, 0.6 g/ml), which possessed four OH groups at C-3, C-7,
C-3, and C-4. In some cases, an association with the presence of
a catechol moiety in ring B and higher leishmanicidal activity was
apparent; e.g., quercetin with a catechol function (IC50, 1.0 g/
ml) was almost three times more active than kaempferol with a
p-hydroxyphenyl ring (IC50, 2.9 g/ml) and morin with two
meta-positioned OH functions at C-2 and C-4 (IC50, 2.8 g/
ml). However, kaempferol was in turn less active than galangin
(IC50, 1.5 g/ml), which bears an unsubstituted B ring. Re-
markably, the presence of a pyrogallol function (three ortho-
hydroxyl functions at C-3, C-4, and C-5) on ring B was
unfavorable, because myricetin had activity comparable to
those of only galangin and quercetin. Moreover, robinetin was
nine times less active (IC50, 5.9 g/ml) than its catecholic coun-
terpart, fisetin (IC50, 0.6 g/ml). As in the case of the flavone
subset, the replacement of hydroxyl groups by methoxyl substitu-
ents anywhere on the entire structure significantly reduced or
completely abolished the leishmanicidal activity. Such a relation-
ship was observed for 3-hydroxyflavone and 3-methoxyflavone
(IC50s, 0.7 and 30 g/ml, respectively). Glycosidation of C-3 or
C-5 hydroxyl groups led to a dramatic reduction in the activity
(Table 2).
All flavanone aglycones except for ()-taxifolin had some
leishmanicidal potential, with 5,7-dimethoxy-8-methylflavanone
being the most potent (IC50, 2.4 g/ml), whereas the two fla-
vanone glycosides were inactive (Table 3). Comparison of the
leishmanicidal activities of naringenin, eriodictyol, and ()-taxi-
folin with those of their unsaturated (2,3) derivatives, namely,
apigenin, luteolin, and quercetin, respectively, implied the impor-
tance of the double bond function between C-2 and C-3.
(	)-Gallocatechingallate (IC50, 8.9 g/ml) and (	)-epigal-
locatechingallate (IC50, 19.1 g/ml) were the only flavan-3-ol
type compounds with weak leishmanicidal activities (Table 4).
A comparison of the flavon-3-ols and their flavan-3-ol coun-
terparts was indicative of the essentiality of both the keto
function at C-4 and the 2,3 double bond for antileishmanial
potency. For example, quercetin demonstrated remarkable po-
tency, whereas quercetin analogues [()-catechin or (	)-cat-
echin and ()-epicatechin or (	)-epicatechin] were inactive at
the highest concentration tested (IC50s, 30 g/ml). The same
trend was observed between myricetin (IC50, 1.3 g/ml) and
(	)-epigallocatechin or (	)-gallocatechin (IC50s, 30 g/ml).
In order to gain more structural characteristics for antipro-
tozoal activity, five simple phenolics, namely, catechol, pyro-
gallol, gallic acid, and 2,3-dihydroxybenzoic and 3,4-dihydroxy-
benzoic acids, were also tested (Table 6). Note that only
catechol and pyrogallol and not gallic or 3,4-dihydroxybenzoic
acid inhibited the growth of L. donovani amastigotes.
Among the isoflavone subclass, daidzein and prunetin were
devoid of activity, while the remaining isoflavones, biochanin A
(IC50, 2.5 g/ml), genistein (IC50, 8.0 g/ml), and 3-hydroxy-
daidzein (IC50, 24.0 g/ml), possessed some activity (Table 5).
The coumarins, which contain a benzo-
-chromone skeleton
instead of the benzo--chromone skeleton found in flavonoids,
had either slight or no activity (IC50s, 20 g/ml); the excep-
tion was the linear furanocoumarin bergaptol, which exhibited
an IC50 of 2.5 g/ml (Table 5).
Finally, a number of hydroxy derivatives of cinnamic acid, the
biogenetic precursor of flavonoids and coumarins, were evaluated
(Table 7). Except for cinnamic acid, methyl cinnamate, and

-acetamido cinnamate, all substituted cinnamates displayed mod-
erate activity. Noteworthy were the findings that caffeic and ferulic
acids exhibited equivalent potencies (IC50, 5.6 g/ml) and that hy-
drocaffeic acid was twofold less active than caffeic acid, point-
ing out the importance of the double bond for antileishmanial
potential.
In vitro anti-Trypanosoma brucei rhodesiense activities. All com-
pounds were also assayed for their in vitro activities against the
trypomastigote forms (mammalian stage) of T. brucei rhodesiense.
As shown in Tables 1 to 7, 7,8-dihydroxyflavone demonstrated the
highest growth-inhibitory activity (IC50, 68 ng/ml); this was fol-
lowed by the activities of three molecules with the same IC50 (0.5
g/ml), 3-hydroxyflavone, rhamnetin, and 7,8,3,4-tetrahydroxy-
flavone, as well as catechol (IC50, 0.8 g/ml). Beside these com-
pounds, 13 compounds exhibited remarkable trypanocidal poten-
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tial, with IC50s ranging from 1.0 to 3.0 g/ml. Of these were three
flavones, two flavon-3-ols, three isoflavones, three simple pheno-
lics, and two caffeic acid derivatives. Twenty-eight compounds (15
flavones, 10 flavon-3-ols, 3 flavan-3-ols, and 2 isoflavones) dis-
played anti-T. brucei rhodesiense potential, with IC50s between 3.1
and 10 g/ml.
Although all flavone and flavonols exhibited lethal effects on
T. brucei rhodesiense trypomastigotes, it was generally more
difficult to interpret the data for trypanocidal activity, particu-
larly for the flavones (Table 1). Flavone itself, as well as its
mono- or dihydroxybenzochromone derivatives, had some ac-
tivity, with 7,8-dihydroxyflavone and 6,7-dihydroxyflavone
(IC50, 1.9 g/ml) being the most potent compounds. A clear
trend for the effect of the hydroxylation pattern on ring B was
not observed, but generally, the compounds with a catechol
function at the side chain appeared to have higher trypanocidal
activities. 7,8,3,4-Tetrahydroxyflavone (IC50, 0.5 g/ml) and
3,4-dihydroxyflavone (IC50, 1.1 g/ml) represented the com-
pounds with the best potential. Different trends were observed
by methylation of the OH groups on the flavone structure. In
many cases, methylation was strongly disfavored and resulted
in an enormous reduction in trypanocidal activity. The most
noteworthy examples of this situation were represented by two
pairs: 7,8-dihydroxyflavone and 7,8-dimethoxyflavone (IC50s,
0.068 and 6.1 g/ml, respectively) and 7,8,3,4-tetrahydroxy-
flavone and 7,8,3,4-tetramethoxyflavone (IC50s, 0.5 and 67.2
g/ml, respectively). In some cases, methylation had a less signif-
icant effect on the activities of the flavones. Apigenin-genkwanin
TABLE 2. In vitro antiprotozoal and cytotoxic activities of flavon-3-ols (flavonols)a
Class No. forQSAR Compound
Position(s)
of OH
Position(s) of
OMe (or Me)
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
Standards 0.34b 0.0026c 0.328d 0.008e
Flavon-3-ol 27 3-Hydroxyflavone 3 0.7 (20.6)f 0.5 (28.8) 7.7 (1.9) 14.4
Aglycone 28 3-Methoxyflavone 3 30 24.5 14.3 90
29 3,6-Dihydroxyflavone 3,6 2.5 (4.1) 3.5 (2.9) 7.0 (1.5) 10.2
30 3,7-Dihydroxyflavone 3,7 3.3 (10) 1.7 (19.4) 9.0 (3.7) 32.9
31 7-Methoxyflavonol 3 7 11.9 2.4 19.8 90
32 Galangin 3,5,7 1.5 (16.5) 16.5 (1.5) 19.8 (1.3) 24.8
33 Kaempferol 3,5,7,4 2.9 (12.9) 9.2 (4.1) 23.9 (1.6) 37.5
34 Kaempferide 3,5,7 4 11.3 25.4 20.6 90
35 Morin 3,5,7,2,4 2.8 38.3 30 90
36 Fisetin 3,7,3,4 0.6 (64.2) 3.3 (11.7) 30 38.5
37 Quercetin 3,5,7,3,4 1.0 (37.1) 8.3 (4.5) 30 37.1
38 Tamarixetin 3,5,7,3 4 16.8 (2.5) 14.8 (2.8) 6.4 (6.6) 42.0
39 Isorhamnetin 3,5,7,4 3 3.8 (10.7) 8.9 (4.6) 30 40.6
40 Rhamnetin 3,5,3,4 7 4.6 0.5 12.1 90
41 3,4-Dimethylquercetin 5,7,3 3,4 7.9 (0.4) 4.5 (0.7) 17.7 (0.2) 3.0
42 Quercetin-3,7,3,4-
tetramethylether
5 3,7,3,4 7.8 (1.7) 47.4 (0.3) 30 13.1
43 Quercetagetin 3,5,6,7,3,4 10.9 (2.7) 3.1 (9.5) 17.1 (1.7) 29.4
44 Robinetin 3,7,3,4,5 5.9 (9.1) 5.3 (10.1) 30 53.5
45 Myricetin 3,5,7,3,4,5 1.3 (28.2) 15.9 (2.3) 30 36.7
46 Syringetin 3,5,7,4 3,5 30 6.1 (3.5) 30 21.5
47 Myricetin trimethylether 3,5,7 3,4,5 30 6.0 (13.6) 30 81.7
Glycoside Kaempferol-3-O-glucoside 5,7,4; 3-O-Glu 20.4 70.1 30 90
Kaempferol-3-O-rutinoside 5,7,4; 3-O-Rut 30 84.5 30 90
Hyperoside 5,7,3,4; 3-O-Gal 30 23.2 30 90
Quercitrin 5,7,3,4; 5-O-Rha 17.7 27.9 30 90
Rutin 5,7,3,4; 3-O-Rut 30 42.1 30 90
a The IC50s are mean values from at least two replicates (the variation is a maximum of 20%). Abbreviations: Glu, glucose; Rut, rutinose (6-O-rhamnopyranosyl-
glucose); Gal, galactose; Rha, rhamnose; OMe, methoxyl; Me, methyl.
b Reference compound, miltefosine.
c Reference compound, melarsoprol.
d Reference compound, benznidazole.
e Reference compound, phodophyllotoxin.
f Selectivity indices are given in parentheses.
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(IC50s, 5.1 and 8.0 g/ml, respectively) and scutellarein-lada-
nein-cirsimaritin (IC50s, 4.6, 2.5, and 3.3 g/ml, respectively) or
luteolin-diosmetin-luteolin tetramethylether (IC50s, 3.7, 6.1, and
4.4 g/ml) had such a relationship. A different behavior was
observed between chrysin (IC50 5.3 g/ml) and its methoxylated
derivatives. Tectochrysin, the monomethoxy derivative, was al-
most inactive (IC50, 86.2 g/ml), whereas chrysin dimethylether
had trypanocidal activity (IC50, 7.9 g/ml) almost comparable to
that of chrysin.
The most potent members that emerged from the flavon-
3-ol subset were 3-hydroxyflavone and rhamnetin (IC50s 0.5
g/ml) (Table 2). Among the compounds with a dihydroxy-
chromone substructure, the most active one was 3,7-dihydroxy-
flavone (IC50, 1.7 g/ml). As in the case of galangin (IC50, 16.5
TABLE 3. In vitro antiprotozoal and cytotoxic activities of flavanone aglycones and glycosidesa
Class No. forQSAR Compound
Position(s)
of OH
Position(s) of
OMe (or Me)
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
Flavanone 49 Naringenin (2S) 5,7,4 5.0 46.1 30 90
50 5,7-Dimethoxy-8-methylflavanone 5,7;8-Me 2.4 (15.5)b 11.7 (3.2) 13.6 (2.7) 37.3
51 5,4-Dihydroxy-6,7-dimethoxyflavanone 5,4 6,7 13.2 (3.0) 25.4 (1.6) 30 39.4
52 Eriodictyol (2S) 5,7,3,4 10.4 (5.3) 24.3 (2.3) 14.5 (3.8) 55.6
53 ()-Taxifolin (2R,3R) 3,5,7,3,4 30 14.6 30 90
Glycoside Hesperidine (2S) 5,3; 7-O-Rut 4 30 44.5 30 90
Neohesperidine 5,3; 7-O-Glu-Rha 4 30 11.5 30 90
a The IC50s are mean values from at least two replicates (the variation is a maximum 20%). The reference compounds and their IC50s are shown in Tables 1 and
2. Abbreviations: Glu, glucose; Rut, rutinose; Rha, rhamnose; OMe, methoxyl; Me, methyl.
b Selectivity indices are given in parentheses.
TABLE 4. In vitro antiprotozoal and cytotoxic activities of flavan-3-ol subclassa
Compound No. forQSAR R
Positions of
OH
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
()-Catechin (2R,3S) 54 H 3,5,7,3,4 30 14.5 90 90
(	)-Catechin (2S,3R) 55 H 3,5,7,3,4 30 22.1 90 90
()-Epicatechin (2S,3S) 56 H 3,5,7,3,4 30 16.8 90 90
(	)-Epicatechin (2R,3R) 57 H 3,5,7,3,4 30 21.2 90 90
(	)-Gallocatechin (2S,3R) 58 H 3,5,7,3,4,5 30 16.3 (1.1)b 90 18.5
(	)-Epigallocatechin (2R,3R) 59 H 3,5,7,3,4,5 30 4.0 (3.7) 80.7 (0.2) 14.6
(	)-Catechingallate (2S,3R) 60 Galloyl 3,5,7,3,4 30 15.2 90 90
(	)-Epicatechingallate (2R,3R) 61 Galloyl 3,5,7,3,4 30 22.7 90 90
(	)-Gallocatechingallate (2S,3R) 62 Galloyl 3,5,7,3,4,5 8.9 (1.7) 3.7 (4.0) 90 14.8
(	)-Epigallocatechingallate (2R,3R) 63 Galloyl 3,5,7,3,4,5 19.1 (0.8) 9.3 (1.6) 90 14.7
a The IC50s are mean values from at least two replicates (the variation is a maximum of 20%). The reference compounds and their IC50s are shown in Tables 1 and 2.
b Selectivity indices are given in parentheses.
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g/ml), additional OH groups on the benzochromone ring
(particularly at C-5) unexpectedly reduced the trypanocidal
potential. Similar to the finding observed for flavones, an ob-
vious trend for the impact of the number and the pattern of
hydroxylation on ring B was absent. However, by using galan-
gin (with a B ring completely free of hydroxyl groups) as a
model, it was notable that the presence of a p-hydroxyphenyl
side chain (e.g., kaempferol [IC50, 9.2 g/ml]) improved the
activity, which, in turn, was almost comparable to that observed
for quercetin (IC50, 8.3 g/ml), which contains a 3,4-ortho-
dihydroxyphenyl moiety. Again, the presence of a third ortho-
hydroxyl function (pyrogallol) in ring B was unfavorable with
respect to the trypanocidal activity (myricetin [IC50, 15.9 g/
ml]). Nevertheless, the activities of these compounds were still
much higher (fourfold) than that observed for morin (IC50,
38.3 g/ml), which bears two meta-positioned hydroxyl groups
in ring B. The influence of the methylation of the OH groups
on both benzochromone and the side chain was quite unclear.
The most interesting examples were quercetin and its methoxy
derivatives. The 3- or 4-monomethylethers of quercetin,
tamarixetin, and isorhamnetin had trypanocidal activities
(IC50s, 14.8 and 8.9 g/ml) either equal to or less than that of
quercetin (IC50, 8.3 g/ml). 3,4-Dimethylquercetin had a two-
fold greater potency (IC50, 4.5 g/ml), whereas quercetin-
3,7,3,4-tetramethylether was five times less active (IC50, 47.4
g/ml) than the title compound. Most strikingly, rhamnetin,
which contains a methoxyl group at C-7, had prominent
trypanocidal activity (IC50, 0.5 g/ml). Again, the dimethyl-
and trimethylether derivatives of myricetin had higher in vitro
potentials than myricetin itself. All flavone or flavonol glyco-
sides were far less potent than their nonglycosidic counterparts
(aglycones), and their activities ranged from 23.2 to 84.5 g/ml
(Table 2).
All members of the flavanone subclass were found to have
some potential to inhibit the growth of African trypanosomes
(Table 3). When the trypanocidal activities of the flavones, e.g.,
apigenin (IC50, 5.1 g/ml) and cirsimaritin (IC50, 3.3 g/ml), were
compared to those of their flavanone counterparts, namely, nar-
ingenin and 5,4-dihydroxy-6,7-dimethoxyflavanone, respectively
(IC50s, 46.1 and 25.4 g/ml, respectively), the key role of the
2,3 double bond for bioactivity became apparent. Except
for (	)-epigallocatechin and (	)-gallocatechingallate (IC50s,
4.0 and 3.7 g/ml), the compounds from the flavan-3-ol sub-
class were also only moderately active (Table 4). This high-
lights the fact that not only the 2,3 double bond but also the
ketone function at C-4 are important for the trypanocidal activity.
The exceptions were (	)-gallocatechin (IC50, 16.3 g/ml) and
(	)-epigallocatechin, which were as active or more active than
their analog compound, myricetin (IC50, 15.9 g/ml).
All isoflavone aglycones tested were highly active, with ge-
nistein (5,7,4-OH) being the most potent and prunetin (5,4-
dihydroxy,7-methoxy) being the least potent (Table 5). Note-
worthy is that methylation of the hydroxyl groups on the
benzochromone ring has a greater (negative) effect (prunetin
[IC50, 12.9 g/ml]) on activity than methylation on the side
chain (biochanin A [IC50, 3.2 g/ml]). The coumarins were
TABLE 5. In vitro antiprotozoal and cytotoxic activities of isoflavones and coumarinesa
Class No. forQSAR Compound
Position(s)
of OH
Position of
OMe (or Me)b
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
Isoflavone 64 Daidzein 7,4 30 5.5 90 90
65 Genistein 5,7,4 8.0 (2.6)c 1.3 (16.1) 23.4 (0.9) 20.9
66 Demethyltexasin 6,7,4 15.9 (1.3) 2.4 (8.8) 30 21.0
67 3-Hydroxydaidzein 7,3,4 24.0 (0.9) 1.62 (13.1) 4.7 (4.5) 21.3
68 Prunetin 5,4 7 30 12.9 (0.4) 8.0 (0.7) 5.8
69 Biochanin A 5,7 4 2.5 (26.3) 3.2 (20.6) 20.0 (3.3) 65.8
Coumarine Scopoletin 7 6 30 31.0 90 90
4-hydroxycoumarine 4 23.5 90 90 90
Umbelliferone 7 27.9 51.8 90 90
4-Methylumbeliferone 7 4-Me 27.1 (3.2) 40.4 (2.2) 90 87.0
6,7-Furanocoumarine Bergapten 5 30 44.6 90 90
Bergaptol 5 2.5 (35.4) 22.1 (4.0) 68.0 (1.3) 88.5
7,8-Furanocoumarine Angelicin The structure is
shown above
24.5 (2.3) 18.7 (3.0) 84.6 (0.7) 55.2
a The IC50s are mean values from at least two replicates (the variation is a maximum of 20%). The reference compounds and their IC50s are shown in Tables 1 and 2.
b OMe, methoxyl; Me, methyl.
c Selectivity indices are given in parentheses.
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only slightly active or inactive against T. brucei rhodesiense
(Table 5). Among the phenylpropanoids tested, caffeic and
hydrocaffeic acids exhibited the highest growth inhibition
against T. brucei rhodesiense (Table 7). Both compounds con-
tain an ortho-dihydroxyphenyl structure, which appears to be
crucial for the trypanocidal activity. Ferulic acid, the 3-methoxy
derivative of caffeic acid, was far less potent (30-fold) than caffeic
acid. Four of five simple phenolic compounds, catechol, pyro-
gallol, gallic acid, and 3,4-dihydroxybenzoic acid, which contain
two or three OH groups positioned ortho to each other revealed
significant trypanocidal activities, with IC50s ranging from 0.8 to
2.9 g/ml (Table 6). The activity of 2,3-dihydroxybenzoic acid was
only marginal (IC50, 62.5 g/ml).
In vitro anti-Trypanosoma cruzi activity. Contrary to the
activity observed for African trypanosomes, the test com-
pounds displayed much weaker growth inhibition against the
trypomastigote forms of American T. cruzi (Tables 1 to 7). The
highest potentials were exhibited by chrysin dimethylether and
the isoflavone 3-hydroxydaidzein (IC50s, 3.9 and 4.7 g/ml,
respectively). Nine additional compounds represented by three
flavones, four flavonols, one isoflavone, and a simple phenolic
compound revealed anti-Trypanosoma cruzi activities, with
TABLE 6. In vitro antiprotozoal and cytotoxic activities of simple phenolicsa
Compound R Position(s)of OH
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
Catechol H 3,4 3.5 (3.3)b 0.8 (14.5) 7.5 (1.5) 11.6
Pyrogallol H 3,4,5 4.8 (3.0) 2.0 (7.4) 30 14.7
Gallic acid COOH 3,4,5 30 1.6 (9) 67.0 14.4
2,3-Dihydroxybenzoic acid COOH 2,3 30 62.5 90 90
3,4-Dihydroxybenzoic acid COOH 3,4 30 2.9 90 90
a The IC50s are mean values from at least two replicates (the variation is a maximum of 20%). The reference compounds and their IC50s are shown in Tables 1 and 2.
b Selectivity indices are given in parentheses.
TABLE 7. In vitro antiprotozoal and cytotoxic activities of cinnamic acid derivativesa
Compound Position(s)of OH
Position of
OMeb R
Other
substituent
IC50 (g/ml)
L. donovani T. bruceirhodesiense T. cruzi L6 cells
trans-Cinnamic acid H 30 83.0 30 90
Methyl-cinnamate Mec 30 90 30 20.4

-Acetamido cinnamic acidd H 30 49.8 30 90
o-Coumaric acid 2 H 6.0 43.5 30 90
m-Coumaric acid 3 H 8.5 42.2 30 90
p-Coumaric acid 4 H 6.8 37.2 30 90
3-Methoxycinnamic acid 3 H 9.2 39.7 30 90
4-Methoxycinnamic acid 4 H 9.6 37.4 30 90
Trans-4-nitro-cinnamic acid H 4 NO2 16.6 (0.2)
e 75.4 (0.04) 30 2.7
Caffeic acid 3,4 H 5.6 (9.5) 1.1 (48.5) 30 53.3
Hydrocaffeic acid(1,2saturated) 3,4 H 12.9 (1.3) 1.2 (14.2) 30 17.0
Ferulic acid 4 3 H 5.6 33.0 30 90
a The IC50s are mean values from at least two replicates (the variation is a maximum of 20%). The reference compounds and their IC50s are shown in Tables 1 and 2.
b OMe, methoxyl.
c Me, methyl.
d The structure is shown above.
e Selectivity indices are given in parentheses.
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IC50s less than 10 g/ml. Among the remaining compounds,
the flavones (n  13), flavonols (n  6), and isoflavones (n 
2) had some weak activity (IC50s, 10 to 30 g/ml); and all
others were practically inactive. 5,7-Dimethoxy-8-methylfla-
vanone and eriodictyol were the only compounds that showed
some inhibitory potential (IC50s, 13.6 and 14.5 g/ml, respec-
tively), although they lack the 2,3 double bond.
Cytotoxicity for mammalian cells. A primary cell line (L6)
derived from rat skeletal myoblasts was used for the determi-
nation of the relative (selective) toxicities of the test com-
pounds. The selectivity indices (SIs; IC50 value for cytotoxicity
divided by IC50 value for antiprotozoal activity) of the com-
pounds with IC50s less than 90 g/ml against L6 cells were
calculated and given for each parasite (Tables 1 to 7). Overall,
the highest cytotoxicity for mammalian cells was exerted by
trans-4-nitro-cinnamic acid (IC50, 2.7 g/ml), which, inter-
estingly, had either no or marginal toxicity for the parasites
tested (Table 7). This was followed by 3,4-dimethylquerce-
tin and the isoflavone prunetin (IC50s, 3.0 and 5.8 g/ml,
respectively).
Three of the four compounds with marked activity against L.
donovani (3-hydroxyflavone, fisetin, and quercetin) had slight or
no toxicity for mammalian cells (SIs, 20 to 64); only luteolin had
a lower therapeutic index (SI, 11.8). Except for 7,8-dihydroxy-
flavone (SI, 4.6), 3,6-dihydroxyflavone (SI, 4.1), and 3,4-dihydroxy-
flavone (SI, 8.2), the majority of the remaining compounds with
significant leishmanicidal activities, e.g., myricetin, galangin,
scutellarein, ladanein, and apigenin, proved to be weakly cytotoxic
(SIs,10). It was also noteworthy that the flavone glycosides had
broader selectivity indices (SIs,24). The other smaller SI values
shown in Tables1 to 7 generally stem from low antileishmanial
activities.
The cytotoxicity of the most potent anti-Trypanosoma brucei
rhodesiense agent, 7,8-dihydroxyflavone, had great selectivity
for this parasite (SI, 116.2). Rhamnetin also appeared to be
very safe toward mammalian L6 cells (IC50, 90 g/ml). The
other trypanocidal compounds, namely, 3-hydroxyflavone, cate-
chol, 7,8,3,4-tetrahydroxyflavone, and 3,4-dihydroxyflavone,
possessed some cytotoxicity for L6 cells (IC50s, ca. 12 to 22
g/ml); however, the calculated SIs were quite reasonable
(28.8, 14.5, 43.2, and 14.9, respectively). Interestingly, caffeic
acid (SI, 48.5) was far less toxic than hydrocaffeic acid (SI,
14.2), suggesting that the reduction of the double bond in-
creases the cytotoxicity. Several compounds with appreciable
activities, e.g., gallic acid, pyrogallol, 6,7-dihydroxyflavone,
luteolin, cirsimaritin, and (	)-gallocatechingallate, displayed
some toxicity, resulting in low SIs that ranged from 2.5 to 9, but most
of the remaining compounds with notable trypanocidal activities ap-
peared to be selectively toxic to T. brucei rhodesiense.
Due to a moderate anti-Trypanosoma cruzi potential, the SIs
of the most active compounds, i.e., chrysin dimethylether and
3-hydroxydaidzein, appeared to be low (SIs, about 5). This
held true for the remaining nine compounds with moderate
trypanocidal activities (IC50s, 10 g/ml), as their SI values
ranged from 1.2 to 6.6.
In vivo antileishmanial activity. Six flavonoids, luteolin, lu-
teolin-7-O-glucoside, 3-hydroxyflavone, fisetin, quercetin, and
myricetin, were tested in vivo with BALB/c mice infected with
the L. donovani HU3 strain. All samples were injected i.p. at a
dose of 30 mg/kg for 5 days. The positive control drugs were
oral miltefosine and sodium stibogluconate, which were ad-
ministered s.c. Only quercetin showed some in vivo activity by
inhibiting the infection 15.3%, whereas all other flavonoids
were completely inactive (Table 8).
In vivo trypanocidal (anti-T. brucei brucei) activity. Six se-
lected compounds (3-hydroxyflavone, 7,8-dihydroxyflavone,
genistein, catechol, caffeic acid, and hydrocaffeic acid) were
also tested for their in vivo efficacies in mice infected with T.
brucei brucei (STIB795). All compounds were applied i.p. at 50
mg/kg. None of the compounds was able to completely eradi-
cate the parasites. The most potent in vitro trypanocidal agent,
7,8-dihydroxyflavone (IC50, 68 ng/ml), significantly reduced the
level of parasitemia; but the mice relapsed and showed a mean
survival of 13 days, which represents an extension of the length
of survival of 6 days for the untreated control group (Table
9). As two flavonoids, 3-hydroxyflavone and genistein, proved
to be inactive, the other active compounds, rhamnetin and
7,8,3,4-tetrahydroxyflavone, were not tested in vivo.
QSARs. Attempts were made to establish common QSARs
for the compounds of the flavone, flavonol, flavane-3-ol, and
isoflavone groups. The IC50 data for each of the biological
effects under study were transformed to a molar scale. The
four sets of biological activities under study were investigated
for their degree of cross-correlation in order to assess the
possibility that a common structure-activity relationship exists
for the observed effects against the different parasites and
TABLE 8. In vivo activities of selected flavonoids against L. donovani in HU3 in BALB/c mice
Compound tested Dosing regimen(mg/kg)a Injection
Total dose
(mg/kg) % Inhibition  95% CL
b Standard error
of mean
Sbvc,d 15 s.c. 75 63.65  21.45 10.9
Miltefosined 30 p.o.e 150 96.62  0.88 0.4
Luteolin 30 i.p. 150 1.90  25.99 13.3
Luteolin-7-O-glucoside 30 i.p. 150 0 13.9
3-Hydroxyflavone 30 i.p. 150 0 12.5
Fisetin 30 i.p. 150 0 4.0
Quercetin 30 i.p. 150 15.39  14.24 7.3
Myricetin 30 i.p. 150 0 10.4
a All doses were given for 5 days.
b CL, confidence limits.
c pentavalent antimony (active ingredient of sodium stibogluconate).
d Standard drugs.
e p.o., perorally.
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mammalian cells, in which case largely identical mechanisms
should underlie the observed effects. However, the degree of
cross-correlation was very low between the four sets of biolog-
ical data. A maximum correlation coefficient (r) of 0.44 was
observed between the T. brucei rhodesiense and L6 cytotoxicity
data, indicating that the data do not follow a common struc-
ture-activity relationship; i.e., that the biological effects are
based on largely different mechanisms.
In order to elucidate possible QSARs for each compound
with biological activity, molecular models were generated for
each of the nonglycosidic compounds (n  68; for QSAR
numbering, see Tables 1 to 5; amentoflavone was the sole
biflavone in the series but was excluded since such singular
structures can generally be expected to lead to problems with
statistical modeling). A large variety of 241 molecular descrip-
tors (numerical expressions encoding information on many
aspects of the compounds’ electronic, steric, and other molec-
ular properties; a full list of these descriptors may be obtained
from one of the authors [T.J.S.]) was calculated on the basis of
the lowest-energy conformer of each compound. The resulting
matrix of independent variables was then investigated for cor-
relations with the biological data [as 	log IC50 (M)  pIC50
(negative decadic logarithm of molar IC50)] by using PLS anal-
ysis. This method is widely used in QSAR and quantitative
structure-property relationship studies in order to combine the
information content of large descriptor matrices in a new set of
few information-rich latent variables (PLS analysis compo-
nents) which best mirror the influences of certain structural
properties on bioactivity (22).
None of the series of biological data led to a statistically
relevant correlation with the descriptors taken into account.
The correlations obtained in this way by PLS analysis in no
case reached a value greater than 0.5 for the cross-validated
correlation coefficient (q2), which is generally considered to
indicate a biologically relevant QSAR model. Since this diffi-
culty might be due to the fact that compounds from different
structural subgroups follow separate QSARs, PLS analysis cal-
culations were also performed for the subset of flavones and
flavonols and for both of these groups separately. However,
none of the correlations obtained by PLS analysis reached the
critical value. As a possible explanation, the molecular features
important for the activities under study may not have been
adequately represented in the descriptor matrix. This might,
e.g., be the case because the activity is due to interactions with
a common (putative) receptor site in a particular common
orientation.
An attempt was therefore made to establish a QSAR model
for the activity against T. brucei rhodesiense (which shows the
largest variance of the four sets of biological data) by using the
receptor-binding site modeling program Raptor (20). Raptor is
based on an alignment of the molecules in the assumed bio-
active conformation and orientation. Based on the aligned
molecules, the shape of a putative receptor pocket is modeled
along with its surface properties in terms of hydrogen bonding
and hydrophobic interactions and the induced fit phenomena
which best reproduce the binding affinity of each compound, as
estimated from the IC50 data. The data set was split into a
training set of 53 compounds, which is used by the program to
build a receptor model, and a test set of 14 compounds, which
are not taken into account during receptor modeling and
whose activities (binding affinities) are predicted with the
model obtained. As in the PLS analysis modeling study, it
turned out that the statistical significance of the correlation
between the binding energies predicted by the Raptor model
and those calculated from the IC50s was low. Figure 1A shows
a plot of the predicted versus the experimental pIC50s. The
average root mean square errors of both the training and the
test sets are quite high (factors of 2.3 and 2.8 in the IC50s,
respectively), and the correlation between the predicted and
the experimental pIC50s was very poor (q
2  0.36 and 0.09 for
the training and the test sets, respectively). In order to test
whether this slight positive correlation was of any biological
relevance, a scramble test was carried out, in which the bioac-
tivity data were randomly assigned to the compounds of the
training set and the model-building process was repeated in
essentially the same way. In cases where a model reflects a
“true” SAR, the model resulting from a scramble test must
generally lead to a much poorer correlation between the pre-
dicted and the experimental data than that obtained with the
real biological data (20). In the case of the present data set, the
result of the scramble test was of approximately the same
statistical quality as that described above, clearly showing that
the latter is a result of a chance correlation (Fig. 1B). It must
be concluded that the compounds in the present data set do
not follow a common structure-activity relationship that can be
deciphered by two independent QSAR methods. This may be
due to the structure of the data set in association with a rela-
tively small variance in the activities in the four sets of biolog-
TABLE 9. In vivo activities of selected compounds against T. brucei brucei STIB795 mouse model
Compound tested Dosing regimen(mg/kg)a Injection
Total dose
(mg/kg)
No. of mice cured/
no. of mice infected
Mean survival
time (days)
Controlb 0/4 6.0
Pentamidinec 5.0 i.p. 20 4/4 30
Melarsoprolc 2.0 i.p. 8 4/4 30
3-Hydroxyflavone 50 i.p. 200 0/4 5.5
7,8-Dihydroxyflavone 50 i.p. 200 0/4 13
Genistein 50 i.p. 200 0/4 6.5
Catechol 50 i.p. 200 0/4 5.75
Caffeic acid 50 i.p. 200 0/4 5.75
Hydrocaffeic acid 50 i.p. 200 0/4 5.75
a All doses were given for 4 days.
b Untreated control used to determine the mean survival.
c Standard drugs.
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ical data and/or by the nonexistence of a true common mech-
anism of action.
DISCUSSION
We previously reported on the antiprotozoal activities of two
flavonoid glycosides (17). This prompted us to screen a large
set of polyphenolic compounds mainly of a flavonoid nature
and thereby to attempt to gain deeper insights into the struc-
tural characteristics necessary for their in vitro trypanocidal
and leishmanicidal activities. As selectivity is the other relevant
characteristic for defining lead candidates, the cytotoxic poten-
tials of the compounds for primary mammalian cells were also
determined and compared to the corresponding antiparasitic
activities. We believe that this is the first (and the most) com-
prehensive study performed with polyphenols so far. The ac-
tivities against L. donovani and T. brucei rhodesiense of many
of the compounds investigated here (including the most
potent ones, such as 3-hydroxyflavone, fisetin, myricetin,
3,7-dihydroxyflavone, 7,8-dihydroxyflavone, and catechol)
are being reported for the first time. It is noteworthy that
some flavones, such as 3-hydroxyflavone, 3,6-dihydroxyflavone,
3,7-dihydroxyflavone, 3,4-dihydroxyflavone, cirsimaritin,
ladanein, and biochanin A, potently inhibit both T. brucei rhod-
esiense and L. donovani parasites with almost equivalent IC50s.
The first four compounds are of special interest, as they are
also able to kill Trypanosoma cruzi to some extent. On the
other hand, some of the phenolic compounds tested (e.g.,
luteolin, quercetin, gallic acid, and 3,4-dihydroxybenzoic acid)
are well known for their inhibitory activities against Leishma-
nia and Trypanomosoma parasites (18, 23, 26); however, the
IC50s obtained in our study are generally much lower (2- to
40-fold). We believe that these discrepancies derive from the
use of different methods and different life cycle stages of the
parasites. The IC50s for Leishmania donovani of caffeic acid
and a few of the catechins were consistent with the values
described in the literature (19, 30). On the other hand, some of
our results conflict with data reported previously: Paveto and
coworkers have recently reported that green tea catechins,
particularly gallocatechingallate and epigallocatechingallate, in-
hibit both bloodstream trypomastigote and amastigote forms T.
cruzi at pM concentrations (29). In our studies, all catechin de-
rivatives were practically inactive against T. cruzi. Instead, (	)-
gallocatechingallate and (	)-epigallocatechingallate were reason-
ably toxic against bloodstream trypomastigote forms of T. brucei
rhodesiense. As catechin-type compounds are well known for their
instability, we tested them immediately after dissolving them in
dimethyl sulfoxide in order to exclude the use of decomposed
material. These differences most likely stem from the different
formats of the assays.
Based on the information obtained, it is difficult to decipher
empirical SARs and/or QSARs among the plant polyphenols
investigated in the current study. Noteworthy is the finding that
the majority of the most active trypanocidal and leishmanicidal
compounds have a typical flavone structure (2,3 and C-4 keto
function) and/or an unhindered catechol substructure (either
on ring B or on the benzochromone skeleton, e.g., 7,8-dihy-
droxyflavone). The other clear trend observed for flavones and
flavonols was that the methylation of the OH groups was dis-
FIG. 1. (A) Plot of the pIC50s predicted by the Raptor model versus the experimental data. (B) Result of a scramble test obtained under the
same conditions with randomly assigned biological activity. Filled circles, test set; open squares, training set; RMS, root mean square; Max,
maximum; pK(pred), predicted negative decadic logarithm of binding constant; pK(exp), experimental negative decadic logarithm of binding
constant (as derived from IC50 value); p2, squared correlation coefficient of predicted versus experimental data for the test set; K, thousands.
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favored and reduced the leishmanicidal activity significantly.
However, this trend was not so clear among the isoflavone
subclass, and in fact, the situation between genistein (4-OH)
and biochanin A (4-methoxy) was the opposite. The influence
of methylation of the hydroxyl groups on trypanocidal activity
was irregular. It generally potentiated the activities of the fla-
vonols and the caffeic acid derivatives, but the situation was
mostly the opposite for flavones. Hence, in line with the diffi-
culties with the interpretation of the data for SARs on an
empirical basis, it was also not possible to establish any clear
QSARs based on those data by the different modeling ap-
proaches applied here. This may be explained by a variety of
reasons. The first possibility is that a common SAR simply does
not exist for the compounds under study. Second, the range of
biological data (i.e., the difference between the most active and
the least active compounds) was relatively low for three of the
four data sets (L. donovani, T. cruzi, and L6 cells); and in the
case of the T. brucei rhodesiense data, although the spread was
wider, only a few highly active compounds were present. In the
absence of a sufficiently large spread in the dependent variable
(here, biological activity), it is generally difficult to obtain sta-
tistically significant linear correlations. Finally, despite the
large variety of properties taken into account in two different
QSAR approaches (descriptors with proven relevance in
QSAR correlations, as well as a validated three-dimensional
binding site modeling technique), it is still possible that the
structural factors underlying the variance of the biological ef-
fects are not represented in the chosen molecular descriptions
in an adequate way.
Polyphenols, such as flavonoids, aromatic acids, and cin-
namates, are abundant constituents of our diet; and evidence
for their role in the prevention of many degenerative diseases
is emerging (25). Previously, it was believed that these mole-
cules could not be absorbed at all after oral ingestion; however,
this view has been overturned by the pioneering work of Holl-
man and coworkers in 1995 (11). It is now clear that flavonoids
are absorbed into plasma; however, the level of absorption is
generally very low and the extent of absorption, bioavailability,
and biological activity is highly dependent on the nature of the
flavonoid. Bioavailability studies have shown that the circulat-
ing form of most flavonoids is as a conjugate (formed by de-
glycosylation, glucuronidation, sulfation, and methylation re-
actions mediated by a range of enzymes in the small intestine,
liver, and colon), which is then excreted into bile and urine
(36). For example, after the oral consumption of quercetin,
one of the most prevalent flavonoids found in edible plants, no
free aglycone is detectable in the plasma; but its conjugates
are detectable (24). The bioactivities of the conjugated poly-
phenols remain virtually uninvestigated. Furthermore, since meta-
bolism might transform one class of flavonoid into another
(28), new pharmacological activity or the loss of previous ac-
tivity can be observed. All these facts may underlie the absence
of notable in vivo activity for the majority of the polyphenols
investigated here. However, 7,8-dihydroxyflavone and querce-
tin appeared to have some in vivo activity. Therefore, they
could serve as pharmacophore models for the rational design
of synthetic analogs with higher in vitro and in vivo activities
and more favorable chemical properties.
Chemotherapy of parasitic diseases still represents a major
challenge. Drug efficacy is mostly limited by the inability of the
pharmaceutical to reach its target in a sufficient concentration
and for a sufficient duration. Compartmentalization of the
pathogen in a parasitophorous vacuole, as in the case of Leish-
mania, requires the drug to cross an additional membrane.
Hence, only a few recommended antiparasitic agents are able
to reach the pathogens at their specific locations, leaving the
rest to be distributed throughout the body without beneficial
effects. On the other hand, the high dosage and the length of
application often result in serious side effects (15). At this
point, it seems that site-directed drug formulation could be a
very useful means to solve these problems. Optimization of
drug carrier and drug delivery systems (e.g., liposomes, poly-
meric nano- and microparticles, and nanosuspensions) have
also been proven to be very effective for the treatment of
visceral leishmaniasis (8, 14). We believe that adaptation of
new drug formulations and delivery strategies will certainly
improve the in vivo antiparasitic activities and bioavailabilities
of flavonoids (particularly those of 7,8-dihydroxyflavone and
quercetin) and reduce the risk of adverse effects.
In conclusion, the flavonoids and their analogues tested here
proved to have very promising in vitro antiprotozoal potentials
with minimum or no cytotoxicity. By screening a library com-
posed of more than 100 flavonoids and similar polyphenolics,
however, we were able to draw only a few SARs, indicating that
the detection of SARs within the polyphenol class is a very
complex task. As polyphenols are one of the largest groups of
natural products, we conclude that a much larger library needs
to be tested in order to reach meaningful SARs. It was partic-
ularly noteworthy that, despite their excellent in vitro activities,
most of the polyphenols selected were devoid of in vivo effi-
cacy. Nevertheless, the current study suggests the in vivo po-
tentials of 7,8-dihydroxyflavone and quercetin and encourages
us to use a medicinal chemistry approach to develop more
potent derivatives as lead compounds. Furthermore, we are
currently trying to identify the potential molecular target(s) of
these two compounds. The determination of their exact mech-
anism(s) of action in association with an efficient drug delivery
strategy will eventually reveal a deeper understanding about
the real antiparasitic potential of flavonoids.
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